WHAT DOCTORS READ:CHEMOTHERAPY:LEUKAEMIA RISK

Women who receive certain forms of chemotherapy or drugs combined with radiation for breast cancer are at increased risk of developing leukaemia.


The National Cancer Institute in Bethesda, Maryland, studying 82,700 women diagnosed with breast cancer around the United States, concluded that the risk of leukaemia was increased two and a half times after localized radiotherapy. Using alkylating agents alone increased the risk 10 fold, combined radiation and drug therapy, by 17 times and 31 times by the chemotherapy drug melphalan, which was 10 times that of cyclophosphamide, another drug used to treat cancer.


There was little increase in the risk associated with cyclophosphamide doses of less than 20,000 mg.


“Systemic drug therapy combined with radiotherapy that delivers high doses to the marrow appears to enhance the risk of leukaemia,” concluded the study.


An editor in the same issue of the New England Journal of Medicine concluded that doctors need to be more “selective” in applying “just in case” therapy to breast cancer patients who have been cured.

What Doctors Don't Tell You Written by What Doctors Don't Tell You

Get the Healthiest Newsletter!

Get a dose of Healthy delivered straight to your inbox. Each FREE issue features amazing content that will elevate your Body, Mind, and Spirit.

Your data is never shared with 3rd parties

Body+Mind+Spirit

TRANSFORM YOUR LIFE?

Try the Internet's Longest-Running Wellness Program.